BIO-Key International Inc reports results for the quarter ended in March - Earnings Summary

BIO-key International

16/05/2023 14:03

* BIO-Key International Inc  BKYI.OQ  reported a quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
March. The lone analyst forecast for the quarter was for a loss
of 27 cents per share.
    * Revenue rose 58.8% to $3.08 million from a year ago;
analysts
expected $2.00 million. 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * BIO-Key International Inc shares had fallen by 7.1% this
quarter and gained 11.1% so far this year.
    * The company reported a quarterly loss of $526 thousand.
    * Wall Street's median 12-month price target for BIO-Key
International Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
16 at 01:03 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.27          -0.08          Beat
 Dec. 31 2022      -0.27          -0.40          Missed
 Sep. 30 2022      -0.16          -0.29          Missed
 Jun. 30 2022      -0.08          -0.21          Missed